Research map: Gender-affirming hormone therapy and migraine: A brief evidence summary and proposal for a new diagnostic entity for ICHD-4
Back to the article
Papers in this map
Sex and Gender Considerations in Episodic Migraine
· Sarah Ahmad · 2022 · 96 citations · Cited by this paper
A randomized controlled trial on combining therapeutic patient education with standard care versus standard care alone for chronic migraine: Effects on patient-reported outcome measures
· 2025 · Related
Headache in transgender and gender‐diverse patients: A narrative review
· Jennifer A. Hranilovich · 2021 · 45 citations · Cited by this paper
Digital screen exposure, lifestyle behaviors, and headache complaints among healthcare students: A multinational study from the MENA region
· 2026 · Related
Gender Minority Stress, Psychiatric Comorbidities, and the Experience of Migraine in Transgender and Gender-Diverse Individuals: a Narrative Review
· Anna Laura Di Pace · 2021 · 29 citations · Cited by this paper
Migraine care in the MENA region, a focus on North Africa
· 2025 · Related
Primary headaches among gender dysphoric female‐to‐male individuals: A cross‐sectional survey on gender transition experience
· Pınar Yalinay Dikmen · 2021 · 25 citations · Cited by this paper
Sex differences in cluster headache, treatment insights, and burden of disease in Türkiye: A multi-center cross-sectional study
· 2026 · Related
Updates on management of headache in women and transgender women
· Jessica Ailani · 2021 · 18 citations · Cited by this paper
Migraine care in the Eastern Europe region
· 2026 · Related
Effect of testosterone therapy on migraine frequency and disability in two transgender patients: a case report
· Candice Todd · 2023 · 15 citations · Cited by this paper
Prospective observational study of three-month response to eCOT-NS device in patients with headache
· 2025 · Related
Molecular mechanisms of hormones implicated in migraine and the translational implication for transgender patients
· Cameron I. Martinez · 2023 · 15 citations · Cited by this paper
Effectiveness and predictors of response to intravenous dihydroergotamine in the treatment of primary headache disorders: A service evaluation
· 2026 · Related
Transgender and Migraine
· E. Anne MacGregor · 2019 · 13 citations · Cited by this paper
Perineural botulinum toxin in the treatment of trigeminal traumatic neuropathic pain
· 2026 · Related
Problems in management of medication overuse headache in transgender and gender non-conforming populations
· Cameron I. Martinez · 2024 · 6 citations · Cited by this paper
Revealing the immune face: TIM3 as a window into T-cell immunity in migraine? – A retrospective cohort study
· 2026 · Related
International Classification of Headache Disorders-4 – Work in progress 2
· Peter James Goadsby · 2025 · 4 citations · Cited by this paper
Patient-reported outcomes from a real-world evidence study in individuals with migraine initiating eptinezumab after ≥1 prior calcitonin gene-related peptide (CGRP)-targeted preventive therapy
· 2026 · Related
Source: OpenAlex (CC0)